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Retrovirus replication critically depends on a dynamic interplay between retroviral and host pro-
teins. We report on the binding of the surface subunit (glycoprotein 120 (gp120)) of the human
immunodeﬁciency virus type 1 (HIV-1) envelope protein (Env) to the cytoplasmic C-terminus of
the voltage-gated potassium channel BEC1 (brain-speciﬁc ether-a-go-go-like channel 1), an interac-
tion that can result in the repression of BEC’s activity and the inhibition of HIV-1 particle-release.
BEC1 protein was found to be expressed in T cells and macrophages, the major target cells of
HIV-1. Thus, gp120/BEC1 interaction may be involved in HIV-1 life cycle and/or pathogenesis.
Structured summary:
MINT-7968695: BEC1 (uniprotkb:Q9ULD8) physically interacts (MI:0915) with gp160 (uniprotkb:P04578)
by anti bait coimmunoprecipitation (MI:0006)
MINT-7968714: BEC1 (uniprotkb:Q9ULD8) physically interacts (MI:0915) with gp160 (uniprotkb:P04578)
by anti tag coimmunoprecipitation (MI:0007)
MINT-7968675: BEC1 (uniprotkb:Q9ULD8) physically interacts (MI:0915) with gp160 (uniprotkb:P04578)
by pull down (MI:0096)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction multigene superfamily, which can be classiﬁed into the ShakerRetroviruses interact with multiple host factors [1,2]. One
example of virus/host cell protein interaction is that of the human
immunodeﬁciency virus type 1 (HIV-1) envelope proteins (Env)
subunit glycoprotein 120 (gp120) with host cell CD4 molecules
and co-receptors [3]. HIV-1 Env is synthesized as a gp160 poly-pro-
tein precursor that is subsequently processed by a host cell prote-
ase to generate the gp120 surface (SU) and gp41 transmembrane
(TM) subunits.
The voltage-gated potassium (K+) channel BEC1 has originally
been described as brain-speciﬁc eag (ether-a-go-go)-like channel
1, due to its predominant expression in human telencephalon [4].
Voltage-gated K+ channels constitute an evolutionary relatedchemical Societies. Published by E
us; gp120, glycoprotein 120;
gated channel subfamily H
Kv11.1
Mueller-Lantzsch).
bra, Infection Biology Group,
Spain.and eag families. Most K+ channels are homotetrameric, with each
subunit containing a voltage sensor and contributing to a central
pore through which K+ ions can permeate [5]. Voltage-gated K+
channels play an essential role in controlling cellular excitability
by allowing K+ to ﬂow out of a cell, thereby restoring the trans-
membrane potential to a negative value after depolarization [5].2. Material and methods
2.1. Cells and plasmids
293T and COS-1 cells were cultured in Dulbecco’s modiﬁed
Eagle medium (DMEM) with 10% fetal bovine serum (FBS). Jurkat
and A3.01 cells were cultured in RPMI 1640 with 10% FBS. Periph-
eral blood mononuclear cells (PBMC) were isolated from buffy
coats by gradient centrifugation using Ficoll-Paque™ Plus (GE
Healthcare). Monocyte-derived macrophages were generated from
PBMC by selective adherence and subsequent culturing in RPMI
1640 with 20% FBS and 5% human AB serum for 6 days. Plasmid
constructs and cloning strategies are described in Supplementary
data.lsevier B.V. All rights reserved.
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Fig. 1. (A) Transmembrane structure of a BEC1 subunit. Membrane-spanning
domains, S1–S6; pore region, P. (B) BEC1 constructs used in this study. Transmem-
brane regions: black boxes. C-terminal sequence used for the generation of the
polyclonal rabbit BEC1-antiserum: grey box. (C) Western blot (WB) analysis of
protein lysates from COS-1 cells transfected with full-length BEC1 (+) or empty
vector () for 48 h. Western blots were developed with BEC1-antiserum (a-BEC1)
either pre-adsorbed (PA) with TrpE alone or with TrpE–BEC1 (823–1083) fusion
protein.
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GST pull-down assays and immunoprecipitation were carried
out as described previously [6]. For co-immunoprecipitations,
293T cells (plated in two 10 cm diameter dishes per experimental
condition) were transfected with pSG5-gp120-HA or pSG5-gp41-
HA (8 lg/dish) using Nanofectin I (PAA). In the experiments
shown in Fig. 2D, cells were co-transfected (8 lg plasmid/dish)
with pSG5-gp120-HA and either pSG5-BEC1-Flag or pSG5-
BEC1(1-861)-Flag. Cells were harvested 48 h after transfection
and immunoprecipitations were performed with anti-BEC1 serum
or pre-immune serum. Western blots were carried out as de-
scribed elsewhere [7]. Membranes were developed with anti-
BEC1 serum at a dilution of 1:1000, a rat monoclonal anti-HA
antibody (3F10, Roche) diluted 1:100, or anti-Flag antibody
diluted 1:500.
2.3. FluxOr™ thallium detection assay
COS-1 cells were plated in 10 cm dishes and co-transfected with
either pSG5-BEC1 or pSG5-BEC1(1-861)-Flag and pSG5-gp120-HA
or pSG5-gp41-HA employing 8 lg of each plasmid and Nanofectin
I (PAA). Two days later, transfected cells were plated at
2  104 cells/well in 96-well plates. BEC1 conductance was mea-
sured with the FluxOr™ thallium detection kit according to the
manufacturer’s protocol (Invitrogen). Following addition of the
stimulus buffer the ﬂuorescence signal was measured every 30 s
on a MR580 Microelisa Autoreader (Dynatech) at 490 nm excita-
tion wavelength.
2.4. HIV-1 particle release assay
293T cells were plated in 10 cm dishes and transfected with
plasmids pSG5-BEC1 or pSG5-BEC1(1-861)-Flag (8 lg/dish) using
Nanofectin I. On the following day, cells were again transfected
(Lipofectamin, Invitrogen) with 4 lg of each of the DNA plasmids
pTN7-Stopp and pENV035x. pTN7-Stopp carries the Renilla lucifer-
ase reporter gene instead of the nef gene and lacks a functional env
gene, thus set to produce only a single-round of infection [8].
pENV035x was a kind gift of Christian Jassoy, University of Leipzig,
and expresses a CCR5-tropic HIV-1 env gene. Co-transfection of the
two plasmids results in the release of pseudo-typed HIV-1 parti-
cles. Virus-containing supernatants were harvested 48 h after
transfection, ﬁltered through 0.45 lm cellulose–acetate ﬁlters
(Schleicher and Schuell), and stored in 1 ml aliquots at 80 C. To
monitor transfection efﬁciency of pTN7-Stopp in 293T cells, Renilla
luciferase activity was measured with a luciferase kit (Promega) in
293T cell lysates 48 h after transfection. HIV-1 particles in the
supernatants were quantitated by a standard p24-ELISA-kit (Bio-
Rad). Additionally, Renilla luciferase activity was measured in
PM1 cells infected with HIV-1 pseudo-typed particle containing
supernatants (details upon request).
3. Results
3.1. Physical interaction of HIV-1 gp120 with the C-terminus of BEC1
To study the binding of gp120 to BEC1 (Fig. 1) in vitro, the C-ter-
minal 224 amino acids of BEC1 (860–1083), and gp120 and gp41
were analyzed by GST pull-down assays (Fig. 2A). gp120 but not
gp41 bound to BEC1 (860–1083). GST pull-down assays with two
fragments of the BEC1 C-terminus further narrowed down the
gp120 interacting region to the C-terminal 111 amino acids
(973–1083) of BEC1 (Fig. 2B). BEC1 protein (117 kDa) was specif-
ically recognized by our rabbit polyclonal anti-BEC1-antiserum(Fig. 1C). We then studied BEC1/gp120 interaction in eukaryotic
cells by co-immunoprecipitation utilizing the BEC1-antiserum. Ini-
tial experiments had revealed that 293T cells constitutively ex-
press BEC1; however, BEC1 protein was only observed in
immunoprecipitated samples but not in total protein lysates, indi-
cating that the levels in 293T cells were low. gp120 but not gp41
was detected in BEC1-immunoprecipitates from 293T cell transfec-
ted to produce gp120 or gp41 (Fig. 2C). Furthermore, Bec1 failed to
interact with Epstein-Barr-Virus LMP1; with the Env transmem-
brane domains of HERV-K, HTLV-1 and HIV-1; and with HERV-K
Gag. These data demonstrate that ectopic gp120 can associate with
endogenously expressed BEC1 in 293T cells. To conﬁrm that HIV-1
gp120 interacts with the C-terminus of BEC1 in living cells, Flag-
tagged full-length BEC1 or Flag-tagged C-terminally truncated
BEC1 (1-861) were co-expressed with gp120 in 293T cells and sub-
sequently immunoprecipitated with an anti-Flag antibody. gp120
was only co-immunoprecipitated with full-length BEC1 (Fig. 2D).
Thus, gp120 binds to the C-terminus of BEC1 in vitro and in living
cells.
3.2. HIV-1 gp120 suppresses BEC-1 activity
We next asked whether the electrophysiological properties of
BEC1 might be affected by gp120. We addressed this question by
employing a Tl+ detection kit that takes advantage of the well-de-
scribed permeability of K+ channels to Tl+ ions [9]. When added to
the culture medium simultaneously with a stimulus to open K+
channels, Tl+ ﬂows through K+ channels down its concentration
gradient into cells. By loading cells with a Tl+-sensitive indicator
dye that shows a strong increase in ﬂuorescence upon Tl+ binding,
Tl+-induced ﬂuorescence can be used as a surrogate indicator for K+
channel activity. In non-transfected COS-1 control cells only a
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Fig. 2. (A) Binding of 35S-labeled gp120 or gp41 (Input) to either GST alone or BEC1 (860–1083) in GST pull-down assays. (B) Binding of gp120–BEC (973–1083). (C) 293T cells
producing BEC1 were transfected with either HA-tagged HIV-1 gp120 (gp120-HA) or gp41 (gp41-HA) for 48 h. Expression of the transfected proteins was conﬁrmed in total
cellular protein lysates (Input). Endogenously expressed BEC1 was immunoprecipitated with BEC1 serum (IP: BEC1 serum) or the corresponding pre-immune serum (IP: BEC1
pre-serum) as control. Western blots (WB) were developed with either BEC1-antiserum (a-BEC1) or an anti-HA antibody (a-HA). BEC1, gp120, and gp41 proteins are marked
by arrows. Asterisks indicate unspeciﬁc background bands. HC, immunoglobulin heavy chains. (D) Interaction of gp120 with the C-terminus of BEC1 in living cells. 293T cells
were co-transfected with gp120-HA and either Flag-tagged full-length BEC1 (BEC1-Flag) or a Flag-tagged C-terminally truncated BEC1 construct (BEC1(1-861)-Flag)) for 48 h.
Immunoprecipitations (IP) were performed with an anti-Flag antibody (a-Flag) and Western blots (WB) were developed with either a-Flag or a-HA antibody. Expression of
gp120 in transfected cells was conﬁrmed in total cellular protein lysates (Input).
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probably resulting from constitutively expressed Tl+ permeable
channels or transporters in these cells (Fig. 3). In contrast, transfec-
tion of COS-1 cells with BEC1 led to a strong increase of the ﬂuores-
cence signal, indicating that the cells expressed functionally intact
BEC1. As a positive control, we also employed COS-1 cells trans-
duced with the well-characterized human voltage-gated K+ chan-
nel potassium voltage-gated channel subfamily H member 2
(hERG) [10]. hERG like BEC1 acted as a Tl+ channel in the Tl+ assay
(Fig. 3). Strikingly, co-expression of BEC1 and gp120 resulted in a
signiﬁcant suppression of BEC1 activity (P = 0.00035), comparable
to the level of non-transfected control cells (Fig. 3, upper panel).
Using increasing amounts of gp120 plasmid DNA (1–8 lg), this
suppressive effect was found to be dose-dependent (data not
shown). In contrast, BEC1 conductance was unaffected in COS-1
cells co-expressing BEC1 and gp41. The C-terminally truncated
BEC1 (1-861) mutant that lacks the gp120-interacting domain in-
duced a robust ﬂuorescence increase in the Tl+ assay, with a max-
imum ﬂuorescence signal only about 25% lower than that of full-
length BEC1. Importantly, in contrast to full-length BEC1, the
gp120 binding-deﬁcient BEC1 (1-861) was not suppressed by
gp120 (Fig. 3, lower panel). Combined, these data strongly suggestthat gp120 can suppress BEC1 conductance through the physical
interaction with its cytoplasmic C-terminus.
3.3. Inhibition of HIV-1 particle release by BEC-1
Interaction of HIV-1 Vpu with the human acid-sensitive back-
ground K+ channel TASK-1 inhibits HIV-1 particle release [11].
We thus wanted to analyze whether the interaction of gp120 and
BEC1 might similarly inﬂuence the release of HIV-1 particles.
293T cells were transfected with either full-length BEC1 or the
truncated BEC1 (1-861) plasmids. Twenty-four hours later cells
were again transfected with an Env-defective HIV-1 proviral con-
struct (pTN7-stopp) carrying a Renilla luciferase reporter gene,
and a plasmid expressing a CCR5-tropic HIV-1 env gene. Superna-
tants were harvested 48 h later and their virus content was quan-
titated by p24 ELISA. As a further quantitation, PM1 cells were
infected with virus present in the supernatants for 48 h and subse-
quently assayed for Renilla luciferase activity (Fig. 4A). Enzyme
activity in the 293T cells was lower in BEC1-transfected cells than
in non-transfected control cells, suggesting that BEC1 inhibits
HIV-1 particle release (data not shown). Full-length BEC1 led to a
twofold reduction of HIV-1 particle release compared to BEC1
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Fig. 3. COS-1 cells were transfected with either full-length BEC1 (upper panel) or a Flag-tagged C-terminally truncated BEC1 construct (BEC1 (1-861), lower panel)) and HA-
tagged gp120 or gp41 as indicated. As a positive control, cells were transduced with the human voltage-gated K+ channel hERG. Untransfected cells (COS-1) served as negative
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consistently observed in both HIV-1 particle detection assays
(p24 ELISA and luciferase assay). To conﬁrm that this reduction
depended upon binding of BEC1 and gp120, BEC1 or BEC1 (1-861)
transfected cells were subsequently transfected with pTN7-stopp
only (no HIV-1 env plasmid). Under these conditions, p24 levels
did not differ in the supernatants of BEC1 and BEC1 (1-861) trans-
fected cells (data not shown). Together, these results indicate that
overexpression of BEC1 inhibits HIV-1 particle release from 293T
cells and that this requires the C-terminus of BEC1.
3.4. Expression of BEC1 in HIV-1 target cells
BEC1 mRNA expression was originally reported to be restricted
to human brain [4]. Nevertheless, a subsequent RT-PCR based
study detected BEC1 mRNA also in various hematopoietic cells
[12]. Immunoprecipitations identiﬁed BEC1 protein in freshly iso-
lated human PBMC and cultured monocyte-derived human macro-
phages, as well as in the human T cell lines Jurkat and A3.01
(Fig. 4C). BEC1 was also observed in COS-1, Gos 3, HeLa, LN405, Ha-
CaT, human ﬁbroblasts, and EBV-transformed B lymphoblastoid
cell lines (data not shown). In sum, our results show that BEC1 is
expressed in target cells of HIV-1.
4. Discussion
We have documented here that the voltage-gated K+ channel
BEC1 expressed in HIV target cells can physically and functionally
interact with HIV-1 gp120 in the cytoplasm. A potentially
important functional consequence is the marked suppression ofBEC1 conductance in cells co-expressing BEC1 and gp120. Inhibi-
tion of K+ channels by HIV-1-encoded proteins, either by direct
interaction or through indirect mechanisms, has been recognized
before: The HIV-1 accessory protein Vpu was shown to physically
interact with the acid-sensitive human K+ channel TASK-1, leading
to the suppression of TASK-1 current [11]. Expression of the HIV-1
accessory protein Nef in CEM lymphocytes inhibited the activity of
a Ca2+-dependent K+ channel [13]. HIV-1 Nef also inactivated a
large-conductance K+ channel in U251 human glial cells [14].
HIV-1 gp160 decreased the current of the voltage-gated K+ channel
Kv1.3 in Jurkat E6.1 cells, probably by increasing the channel’s
phosphorylation [15]. Finally, cardiac myocytes showed a delay
in repolarization associated with a reduction in outward K+ cur-
rents [16]. Together, it therefore seems possible that modulation
of K+ channel activity and the associated changes in the transmem-
brane electric potential may be of relevance for HIV-1 life cycle and
pathogenesis. How does the BEC1/gp120 interaction ﬁt into this
scenario? Notably, HIV-infection of human PBMC caused an in-
crease of intracellular K+ levels that correlated with HIV-1-induced
cytopathic effects [17]. Since BEC1 transports K+ out of the cell,
BEC1 inhibition is likely to cause increased intracellular K+
concentration.
In T lymphocytes, the major target cells of HIV-1, functional K+
channels are required to maintain the negative resting membrane
potential as an important driving force for Ca2+ inﬂux, which in turn
is crucial in the antigen-driven activation of T lymphocytes [18]. In-
deed, high afﬁnity antagonists of K+ channels are known to depolar-
ize human T cells (render the resting membrane potential less
negative), thereby inhibiting Ca2+-dependent T cell activation
[19,20]. Along this line, inhibition of a Ca2+-dependent K+ channel
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Fig. 4. (A) Flow diagram outlining the quantitation of HIV-1 particle release. (B) p24 levels and Renilla luciferase activity (expressed in relative light units [RLU]) from 293T
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immunoprecipitated from the indicated cell lines by BEC1-antiserum. IP: BEC1 pre-serum, protein lysate immunoprecipitated with the corresponding BEC1 pre-immune
serum as a control. Western blots were stained with BEC1-antiserum.
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phocytes [13]. Given the expression of BEC1 in human T cells, it is
thus tempting to speculate that suppression of BEC1 conductance
by HIV-1 gp120 and the subsequent increase of the intracellular
K+ concentration may lead to depolarization of T cells and the sup-
pression of Ca2+-dependent T cell activation cascades. Moreover,
the prominent expression of BEC1 in neurons [4] and the growing
evidence that HIV can infect neurons [21,22] raise the possibility
that BEC1/gp120 interaction is relevant in this tissue as well.
BEC1/gp120 interaction also negatively affected HIV particle re-
lease, probably through interference with the binding of gp120 to
the HIV-1 Gag protein crucial for particle assembly [23]. However,
since BEC1 is a rare protein in all tested cells and gp120 is typically
expressed to high levels in HIV-infected cells, the effect of the BEC1/
gp120 interaction on particle release is likely to be of minor
importance.
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